Recently Sattari et al. 35 found MIAT upregulation in leukemia/lymphoma lymphoid lineage with mature B-cell phenotype; interestingly, they demonstrated a higher incidence of MIAT upregulation in aggressive types of CLL and worst clinical outcome. Here, MIAT is linked to leukemia.